キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/09/12 | 1,197 | 1,240 | 1,159 | 1,232 | +61 | +5.2% | 447,200 |
| 2025/09/11 | 1,174 | 1,184 | 1,155 | 1,171 | -8 | -0.7% | 230,900 |
| 2025/09/10 | 1,165 | 1,198 | 1,136 | 1,179 | +52 | +4.6% | 493,900 |
| 2025/09/09 | 1,200 | 1,225 | 1,100 | 1,127 | -78 | -6.5% | 948,400 |
| 2025/09/08 | 1,190 | 1,239 | 1,184 | 1,205 | -9 | -0.7% | 383,100 |
| 2025/09/05 | 1,196 | 1,220 | 1,185 | 1,214 | +18 | +1.5% | 343,800 |
| 2025/09/04 | 1,272 | 1,274 | 1,182 | 1,196 | -66 | -5.2% | 626,300 |
| 2025/09/03 | 1,352 | 1,375 | 1,251 | 1,262 | -109 | -8% | 698,200 |
| 2025/09/02 | 1,368 | 1,416 | 1,333 | 1,371 | +3 | +0.2% | 731,700 |
| 2025/09/01 | 1,270 | 1,408 | 1,266 | 1,368 | +68 | +5.2% | 899,200 |
| 2025/08/29 | 1,247 | 1,335 | 1,200 | 1,300 | +83 | +6.8% | 1,128,800 |
| 2025/08/28 | 1,356 | 1,378 | 1,167 | 1,217 | -163 | -11.8% | 2,060,100 |
| 2025/08/27 | 1,471 | 1,505 | 1,358 | 1,380 | -71 | -4.9% | 1,688,200 |
| 2025/08/26 | 1,368 | 1,558 | 1,339 | 1,451 | +102 | +7.6% | 2,882,000 |
| 2025/08/25 | 1,275 | 1,394 | 1,244 | 1,349 | -50 | -3.6% | 1,991,100 |
| 2025/08/22 | 1,221 | 1,399 | 1,204 | 1,399 | +202 | +16.9% | 4,542,400 |
| 2025/08/21 | 1,041 | 1,341 | 1,027 | 1,197 | +155 | +14.9% | 6,580,000 |
| 2025/08/20 | 1,065 | 1,072 | 1,042 | 1,042 | -23 | -2.2% | 195,200 |
| 2025/08/19 | 1,062 | 1,072 | 1,048 | 1,065 | +1 | +0.1% | 178,900 |
| 2025/08/18 | 1,055 | 1,072 | 1,049 | 1,064 | +9 | +0.9% | 247,800 |
| 2025/08/15 | 1,050 | 1,066 | 1,044 | 1,055 | +11 | +1.1% | 238,400 |
| 2025/08/14 | 1,031 | 1,058 | 1,027 | 1,044 | +10 | +1% | 226,300 |
| 2025/08/13 | 1,055 | 1,068 | 1,032 | 1,034 | -16 | -1.5% | 235,200 |
| 2025/08/12 | 1,047 | 1,085 | 1,035 | 1,050 | +25 | +2.4% | 367,700 |
| 2025/08/08 | 1,034 | 1,034 | 1,015 | 1,025 | -20 | -1.9% | 201,000 |
| 2025/08/07 | 1,026 | 1,045 | 1,021 | 1,045 | +12 | +1.2% | 172,500 |
| 2025/08/06 | 1,013 | 1,034 | 1,008 | 1,033 | +15 | +1.5% | 207,900 |
| 2025/08/05 | 1,002 | 1,022 | 1,002 | 1,018 | +17 | +1.7% | 175,600 |
| 2025/08/04 | 985 | 1,016 | 982 | 1,001 | -2 | -0.2% | 163,000 |
| 2025/08/01 | 1,013 | 1,023 | 997 | 1,003 | -10 | -1% | 160,200 |
| 2025/07/31 | 1,004 | 1,017 | 998 | 1,013 | +4 | +0.4% | 151,100 |
| 2025/07/30 | 1,000 | 1,014 | 982 | 1,009 | +24 | +2.4% | 215,100 |
| 2025/07/29 | 996 | 1,000 | 985 | 985 | -9 | -0.9% | 175,300 |
| 2025/07/28 | 1,005 | 1,009 | 994 | 994 | -4 | -0.4% | 145,000 |
| 2025/07/25 | 1,011 | 1,014 | 995 | 998 | -17 | -1.7% | 216,200 |
| 2025/07/24 | 1,010 | 1,022 | 997 | 1,015 | +20 | +2% | 181,700 |
| 2025/07/23 | 990 | 1,026 | 990 | 995 | +20 | +2.1% | 313,000 |
| 2025/07/22 | 999 | 1,013 | 969 | 975 | -29 | -2.9% | 387,500 |
| 2025/07/18 | 1,032 | 1,048 | 1,003 | 1,004 | -18 | -1.8% | 186,300 |
| 2025/07/17 | 1,015 | 1,038 | 1,015 | 1,022 | +9 | +0.9% | 146,800 |
| 2025/07/16 | 1,027 | 1,033 | 1,012 | 1,013 | -22 | -2.1% | 168,500 |
| 2025/07/15 | 1,075 | 1,084 | 1,026 | 1,035 | -29 | -2.7% | 326,500 |
| 2025/07/14 | 1,025 | 1,077 | 1,025 | 1,064 | +21 | +2% | 276,400 |
| 2025/07/11 | 1,010 | 1,058 | 1,010 | 1,043 | +31 | +3.1% | 308,200 |
| 2025/07/10 | 1,006 | 1,028 | 997 | 1,012 | +6 | +0.6% | 210,100 |
| 2025/07/09 | 1,009 | 1,028 | 1,004 | 1,006 | -8 | -0.8% | 192,400 |
| 2025/07/08 | 1,007 | 1,021 | 997 | 1,014 | -4 | -0.4% | 195,500 |
| 2025/07/07 | 1,012 | 1,033 | 1,001 | 1,018 | +1 | +0.1% | 218,800 |
| 2025/07/04 | 1,025 | 1,043 | 1,012 | 1,017 | -20 | -1.9% | 242,300 |
| 2025/07/03 | 1,017 | 1,037 | 995 | 1,037 | +23 | +2.3% | 283,100 |
1～
50
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 123,200円 | - | - | 0.00% | - | 8.34倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| ミズホメディ | 158,400円 | -20.7% | -41.2% | 6.00% | 13.50倍 | 1.75倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| レナサイエンス | 192,000円 | -14.4% | - | 0.00% | - | 14.19倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| 扶桑薬 | 218,200円 | +1.6% | -12.7% | 4.12% | 8.10倍 | 0.56倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 30,500円 | - | - | 0.00% | - | 3.23倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム
